Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 56 clinical trials
Selective Omission of Axillary Surgery in Triple-negative and HER2-positive Breast Cancer After NACT

eradicated by NACT and converted to ypN0 indicating the efficacy of systemic treatment in local disease control. According to current guidelines, all initial cN0 patients will undergo sentinel lymph

  • 0 views
  • 05 May, 2022
  • 1 location
Axillary Sentinel or Targeted Lymph Node Biopsy Alone After Neoadjuvant Chemotherapy in Node-positive Breast Cancer

This randomized phase II trial investigates the effectiveness of axillary sentinel or targeted lymph node biopsy alone after neoadjuvant chemotherapy (NAC) in breast cancer patients with initial axillary metastasis. For patients with the low nodal disease after NAC, it is not yet known if radiation therapy causes fewer side effects …

  • 0 views
  • 11 Dec, 2021
  • 1 location
Repeat Sentinel Lymph Node Biopsy in Ipsilateral Breast Tumor Recurrence

conducted in patients with ipsilateral breast tumor recurrence among patients who previously underwent breast conservation and sentinel lymph node biopsy for unilateral primary breast cancer.

breast cancer
cancer surgery
lymph node dissection
partial mastectomy
metastasis
  • 0 views
  • 07 Aug, 2021
  • 1 location
Sentinel Lymph Node Biopsy Versus no Axillary Surgery in Early Breast Cancer (VENUS)

The VENUS trial is a prospective, multicenter, noninferiority, randomized, controlled clinical trial that compares sentinel lymph node biopsy versus no axillary surgery in women with early

HER2
sentinel lymph node biopsy
breast carcinoma
erbb2
mastectomy
  • 0 views
  • 23 Apr, 2022
  • 9 locations
Sentinel Lymph Node Biopsy Versus Pelvic Lymphadenectomy in Early-stage Cervical Cancer (PHENIX/CSEM 010)

The diagnostic value of sentinel lymph node biopsy in early-stage cervical cancer has been well studied. However, there were no randomized controlled study on comparing the long-term outcomes of

squamous cell carcinoma
adenocarcinoma
cervical carcinoma
cancer
lymphadenectomy
  • 3 views
  • 24 Jan, 2021
  • 1 location
Randomized Comparison Between Sentinel Lymph Node Biopsy and Lymph Node Dissection in Early Stage Endometrial Cancer (SELYE)

Through this clinical trial, the investigators aim to verify the usefulness and stability of sentinel lymph node mapping in endometrial cancer of clinical stage I-II.

adenocarcinoma
cancer
hysterectomy
uterine disease
carcinosarcoma
  • 0 views
  • 12 Mar, 2022
  • 1 location
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer

This phase II/III trial studies how well sentinel lymph node biopsy works and compares sentinel lymph node biopsy surgery to standard neck dissection as part of the treatment for early-stage

step 2
mouth cancer
chest x-ray
cancer
ct scan
  • 12 views
  • 04 Oct, 2022
  • 25 locations
Fluorescence for Sentinel Lymph Node Identification in Cancer Surgery (GASVERT)

This is a single-center prospective clinical trial to evaluate non-inferiority of indocyanine green guided sentinel lymph node biopsy compared with the gold standard Technecium99 guided sentinel

cancer surgery
sentinel node
sentinel lymph node biopsy
indocyanine green
probe
  • 34 views
  • 27 Apr, 2022
  • 1 location
Sentinel Node Biopsy Vs Observation After Axillary PET

predictive value of LymphPET and to verify whether sentinel lymph node biopsy can be spared in patients with negative preoperative axillary assessment.

immunostimulant
sentinel node
invasive carcinoma
sentinel lymph node biopsy
axillary lymph node dissection
  • 0 views
  • 25 Jan, 2021
  • 1 location
Randomized Trial of Hypofractionated LocoRegional Radiotherapy in Breast Cancer and Lymphedema (RHEAL) (RHEAL)

The primary objective is to determine if hypofractionated radiotherapy (RT) delivered over 1 week to the breast and regional nodes (supraclavicular, axillary and internal mammary) following breast conserving surgery (BCS), or to the chest wall and regional nodes following mastectomy, is non-inferior to conventional fractionation delivered over 3 weeks in …

breast cancer
invasive carcinoma
breast cancer staging
mastectomy
breast-conserving surgery
  • 0 views
  • 24 Oct, 2022
  • 15 locations